BrightSpring Health Services, Inc. (NASDAQ:BTSG) Stake Lifted by SG Americas Securities LLC

SG Americas Securities LLC raised its stake in BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 50.9% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 37,000 shares of the company’s stock after buying an additional 12,486 shares during the quarter. SG Americas Securities LLC’s holdings in BrightSpring Health Services were worth $630,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Intech Investment Management LLC acquired a new stake in shares of BrightSpring Health Services in the 3rd quarter worth about $159,000. nVerses Capital LLC increased its stake in shares of BrightSpring Health Services by 195.8% in the third quarter. nVerses Capital LLC now owns 14,200 shares of the company’s stock valued at $208,000 after purchasing an additional 9,400 shares during the period. American Century Companies Inc. bought a new stake in shares of BrightSpring Health Services during the second quarter valued at approximately $216,000. BNP Paribas Financial Markets boosted its position in shares of BrightSpring Health Services by 5.0% during the third quarter. BNP Paribas Financial Markets now owns 21,329 shares of the company’s stock worth $313,000 after buying an additional 1,011 shares during the period. Finally, Versor Investments LP bought a new position in BrightSpring Health Services in the 3rd quarter worth approximately $463,000.

Analysts Set New Price Targets

Several brokerages have weighed in on BTSG. Bank of America lifted their target price on BrightSpring Health Services from $19.00 to $21.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. KeyCorp assumed coverage on shares of BrightSpring Health Services in a report on Friday, October 11th. They issued a “sector weight” rating for the company. Morgan Stanley increased their target price on shares of BrightSpring Health Services from $19.00 to $20.00 and gave the company an “overweight” rating in a research report on Tuesday, December 17th. BTIG Research boosted their price target on shares of BrightSpring Health Services from $15.00 to $20.00 and gave the stock a “buy” rating in a research report on Thursday, October 3rd. Finally, UBS Group increased their price objective on shares of BrightSpring Health Services from $22.00 to $30.00 and gave the company a “buy” rating in a report on Wednesday. One research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, BrightSpring Health Services presently has a consensus rating of “Moderate Buy” and a consensus target price of $19.42.

BrightSpring Health Services Price Performance

NASDAQ BTSG opened at $24.24 on Friday. The stock has a market capitalization of $4.22 billion and a P/E ratio of -93.23. The company has a debt-to-equity ratio of 1.63, a quick ratio of 0.97 and a current ratio of 1.35. The business’s fifty day moving average is $18.72 and its two-hundred day moving average is $15.87. BrightSpring Health Services, Inc. has a 1 year low of $7.85 and a 1 year high of $24.82.

BrightSpring Health Services (NASDAQ:BTSG) last announced its earnings results on Friday, November 1st. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.07). The company had revenue of $2.91 billion for the quarter, compared to analysts’ expectations of $2.72 billion. BrightSpring Health Services had a negative net margin of 0.38% and a positive return on equity of 4.16%. The firm’s revenue for the quarter was up 28.8% compared to the same quarter last year. On average, research analysts forecast that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current fiscal year.

BrightSpring Health Services Company Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.